ScopusElsevier Scopus
Status
Active
Coverage
1982–2026
Source type
Journal
Open access
Yes
CiteScore
15.9
Best quartile
Q1 · 95th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 14 / 328 | 95th | Q1 |
Biomedicine and Pharmacotherapy
ISSN 0753-3322 · 1950-6007
Publisher: Elsevier Masson s.r.l.
Scopus · Q1WoS · SCIEOpen AccessONOSONOS APC
15.9
CiteScore 2025
Scopus
Q1
Best quartile
95th percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Authors affiliated with an ONOS-subscribed Indian institution can publish in this journal with the Article Processing Charge (APC) covered centrally under One Nation One Subscription — no personal APC payment.
Eligibility depends on your institution and the current ONOS list, which is subject to revision — verify before submitting.
Check the ONOS APC portal Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.